BioCentury
ARTICLE | Company News

Access Pharmaceuticals, AMAG Pharmaceuticals sales and marketing update

June 17, 2013 7:00 AM UTC

AMAG licensed exclusive, U.S. commercialization rights to MuGard mucoadhesive oral rinse from Access for an upfront payment of $3.3 million. Access is also eligible for a tiered, double-digit royalty...